Skip to main content
Industry News
Teva, Iontas enter deal for biotherapeutics development

Teva Pharmaceuticals and Iontas have partnered to optimize human antibodies to be used for biotherapeutics. Iontas will provide Teva with optimized antibodies for a specific target, with the latter gaining the option to be part of future optimization programs.

Full Story: